Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vaccine Into the Infant Immunization Schedule

NACompletedINTERVENTIONAL
Enrollment

10,000

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

August 31, 2023

Study Completion Date

December 15, 2023

Conditions
Hepatitis B
Interventions
BIOLOGICAL

birth dose vaccination against hepatitis B strategy

"Complex intervention targeting healthcare workers and involving:~* training on hepatitis B awareness and management~* training on EPI vaccination and cold chain~* training on the modalities for the birth dose administration~* the use of a monovalent unidose vaccine against Hepatitis B"

Trial Locations (2)

Unknown

District sanitaire de Dafra, Bobo-Dioulasso

District sanitaire de Do, Bobo-Dioulasso

Sponsors

Lead Sponsor

Collaborators (2)

All Listed Sponsors
collaborator

Agence de Médecine Préventive, France

OTHER

collaborator

Centre Muraz

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Gilead Sciences

INDUSTRY

collaborator

Abbott

INDUSTRY

lead

Institut Pasteur

INDUSTRY